Research Article
BibTex RIS Cite

Kronik ürtikerli hastalarda troid otoimmünitesi ve artmış nötrofil lenfosit oranı

Year 2019, , 52 - 56, 21.03.2019
https://doi.org/10.18663/tjcl.521024

Abstract

Amaç:
 Kronik ürtikerin (KÜ) etyopatogenezi
henüz net değildir. Ancak otoimmünitenin ve inflamasyonun rol oynadığı yapılan
çalışmalarda gösterilmiştir.  Bu
çalışmamızda KÜ’li hastalarda tiroid otoimmünitesinin saptanması, hastalık
şiddetiyle ilişkisinin araştırılması ve inflamatuar belirteçler olan nötrofil
lenfosit oranı (NLO), eosinofil lenfosit oranı (ELO) ve monosit lenfosit
oranlarının (MLO) kontrol grup ile karşılaştırılması amaçlanmıştır.

Gereç ve Yöntemler:
Erişkin allerji-immünoloji polikliniğinde KÜ nedeniyle takip edilen hastaların
kayıtları geriye dönük olarak incelendi. Çalışmaya 100 KÜ’li hasta ve kontrol
grubu olarak 100 sağlıklı birey alındı. KÜ’li hastaların demografik verileri,
yedi günlük ürtikeryal aktivite skorları (UAS 7), kullandığı ilaçlar,
laboratuar verilerinden anti-tiroglobülin (anti-Tg) ve anti-tiroid peroksidaz
(anti-Tpo), antinükleer antikor (ANA) sonuçları ve kan sayımı parametreleri
kayıt edildi. Kontrol grubu olarak yaş ve cinsiyet uyumlu sağlıklı bireylerin
kan sayımı parametreleri kayıt edildi.

Bulgular:
KÜ hastalarda anti-Tpo % 19
hastada pozitif iken, anti-Tg % 8, ANA % 17
hastada pozitif idi. KÜ hastalar UAS 7’ye göre hafif, orta ve şiddetli olarak,
gruplara ayrılarak değerlendirildiğinde, gruplar arası anti-Tpo, anti-Tg ve ANA
sonuçları açısından fark saptanmadı (p>0,05). KÜ hastalar ve kontrol
grupları arasında NLO, MLO ve ELO kıyaslandığında, NLO ve MLO istatistiksel
olarak anlamlı yüksek tespit edilirken (p=0,028, p=0,001, sırasıyla) ELO
açısından istatistiksel olarak anlamlı fark yoktu (p=0,094). KÜ’li hastalarda
NLO, MLO ve ELO değerleri anti-Tpo, anti-Tg ve ANA pozitif ve negatif olan
gruplar arasında kıyaslandığında anlamlı fark saptanmadı (p>0,05).







Sonuç: KÜ’de otoimmünitenin ve inflamasyonun önemi yapılan
çalışmalarda gösterilmişti.  Ek olarak bu
çalışmada hastalık aktivitesi ile tiroid otoimmünitesi arasında ilişki
saptanmazken inflamatuar bir belirteç olan NLO’ya ek olarak MLO da yüksek
olarak tespit edildi. 

References

  • 1. Zuberbier T, Aberer W, Asero R et al. The EAACI/GA2LEN/EDF/WAO guide¬line for the definition, classification, diagnosis and management of urti¬caria. Allergy 2018; 73: 1393-414.
  • 2. Bernstein JA, Lang DM, Khan DA et al. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol 2014; 133: 1270-77.
  • 3. Kocatürk Göncü E, Aktan Ş, Atakan N et al. Türkiye Ürtiker Tanı ve Tedavi Kılavuzu-2016. Turkderm – Arch Turk Dermatol Venerology 2016; 50: 82-98.
  • 4. Tat TS. Higher Levels of Depression and Anxiety in Patients with Chronic Urticaria. Med Sci Monit 2019; 25: 115-20.
  • 5. Ozturk C, Balta S, Balta I et al. Neutrophil–lymphocyte ratio and carotid-intima media thickness in patients with Behcet disease without cardiovascular involvement. Angiology 2014; 66: 291-96.
  • 6. Ma J, Kuzman J, Ray A et al. Neutrophil-to-lymphocyte Ratio (NLR) as a predictor for recurrence in patients with stage III melanoma. Sci Rep 2018; 8: 4044.
  • 7. Antia C, Baquerizo K, Korman A, Bernstein JA, Alikhan A. Urticaria: A comprehensive review: Epidemiology, diagnosis, andwork-up. J Am Acad Dermatol 2018; 79: 599-614.
  • 8. Akarsu S, Ilknur T, Özbagçıvan Ö, Fetil E. Kronik spontan ürtiker ve ürtikeryal vaskülitli olgulardaki eşlik eden durumlar: Retrospektif bir çalışmanın sonuçları. Türkderm 2015; 49: 18-24.
  • 9. Díaz-Angulo S, López-Hoyos M, MuñozCacho P, Fernández M, López-Escobar M, Rodríguez F, González-López MA. Prevalence of thyroid autoimmunity in spanish patients with chronic idiopathic urticaria: a case-controlstudy involving 343 subjects. J Eur Acad Dermatol Venereol 2016; 30: 692-93.
  • 10. Cebeci F, Tanrikut A, Topcu E et al. Association between chronic urticaria And thyroid autoimmunity. Eur J Dermatol 2006; 16: 402-5.
  • 11. Kasumagic-Halilovic E, Beslic N, Ovcina-Kurtovic N. Thyroid Autoimmunity in Patients with Chronic Urticaria. Med Arch 2017; 71: 29-31.
  • 12. Gül Ü, Çakmak S, Gönül M, Soylu S, Kılıç A. Kronik ürtikerde tiroid fonksiyon testleri ve tiroid otoantikorları istenmeli mi? Asthma Allergy Immunol 2009; 7: 39-43.
  • 13. Saraç G, Mantar İ, Sener S, Cenk H, Kapicioglu Y. Assessment of change in neutrophil-lymphocyte ratio, platelet-lymphocyteratio in patients with acute and chronic urticaria.J Tugut Ozal Med Cent 2018; 25: 719-22.
  • 14. Karabay EA, Çerman AA, Altunay İK. Serum C-reactive protein, neutrophil-lymphocyte ratio and uric acid levels in chronic spontaneous urticaria. Turkiye Klin J Dermatology 2016; 26: 125-31.

Thyroid autoimmunity and increased neutrophil lymphocyte ratio in patients with chronic urticaria

Year 2019, , 52 - 56, 21.03.2019
https://doi.org/10.18663/tjcl.521024

Abstract

Aim:
The etiopathogenesis of chronic urticaria (CU) is not clear yet. However, it
has been shown that autoimmunity and inflammation play important roles in most
of the studies. In this study, we aimed to determine the prevalence of thyroid
autoimmunity in patients with CU and to investigate the relationship between
the severity of the disease and thyroid autoimmunity. and also we aimed to
compare the neutrophil lymphocyte ratio (NLR), eosinophil lymphocyte ratio
(ELR) and monocyte lymphocyte ratio (MLR) which are inflammatory markers
between the CU group and the control group.

Material
and Methods:
Medical records of CU patients who were
followed in adult allergy-immunology policlinic were retrospectively analyzed.
A total of 100 patients with CU and 100 healthy subjects were included in the
study. Patients' demographic datas, seven-day urticarial activity scores (UAS
7), drugs that were used, 
anti-thyroglobulin (anti-Tg) and anti-thyroid peroxidase (anti-Tpo),  anti-nuclear antibody (ANA) and blood count parameters
as laboratory data were recorded. As control group blood count parameters of
healthy individuals that age and gender-matched were recorded.

Results:
Anti-Tpo was positive in 19%, anti-Tpo was positive in 8% and ANA was positive
in 17% of the patients with CU. When we divided patients with CU according to
UAS 7 into three groups as mild, moderate and severe,  there were no significant difference between
the groups as anti-Tpo, anti-Tg and ANA results (p>0.05). When we compare
NLR, MLR and ELR parameters between the patients and healthy group,we found
that NLR and MLR parameters were statistically significant higher in patients
groups (P=0.028, p=0.001, respectively) but there was no difference between the
groups as ELR parameter (p=0,094). When we classified patients with CU as
anti-Tpo, anti-Tg and ANA positive and negative,  there were no significant differences between
the groups as NLR, MLR and ELR results (p>0.05).     







Conclusion:
The importance of autoimmunity and inflammation in CU has been shown in
studies. In addition, in this study the relationship between the disease
activity of urticaria and the thyroid autoimmunity was not determined but the
NLR and MLR parameters were found higher in CU as inflammatory markers.

References

  • 1. Zuberbier T, Aberer W, Asero R et al. The EAACI/GA2LEN/EDF/WAO guide¬line for the definition, classification, diagnosis and management of urti¬caria. Allergy 2018; 73: 1393-414.
  • 2. Bernstein JA, Lang DM, Khan DA et al. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol 2014; 133: 1270-77.
  • 3. Kocatürk Göncü E, Aktan Ş, Atakan N et al. Türkiye Ürtiker Tanı ve Tedavi Kılavuzu-2016. Turkderm – Arch Turk Dermatol Venerology 2016; 50: 82-98.
  • 4. Tat TS. Higher Levels of Depression and Anxiety in Patients with Chronic Urticaria. Med Sci Monit 2019; 25: 115-20.
  • 5. Ozturk C, Balta S, Balta I et al. Neutrophil–lymphocyte ratio and carotid-intima media thickness in patients with Behcet disease without cardiovascular involvement. Angiology 2014; 66: 291-96.
  • 6. Ma J, Kuzman J, Ray A et al. Neutrophil-to-lymphocyte Ratio (NLR) as a predictor for recurrence in patients with stage III melanoma. Sci Rep 2018; 8: 4044.
  • 7. Antia C, Baquerizo K, Korman A, Bernstein JA, Alikhan A. Urticaria: A comprehensive review: Epidemiology, diagnosis, andwork-up. J Am Acad Dermatol 2018; 79: 599-614.
  • 8. Akarsu S, Ilknur T, Özbagçıvan Ö, Fetil E. Kronik spontan ürtiker ve ürtikeryal vaskülitli olgulardaki eşlik eden durumlar: Retrospektif bir çalışmanın sonuçları. Türkderm 2015; 49: 18-24.
  • 9. Díaz-Angulo S, López-Hoyos M, MuñozCacho P, Fernández M, López-Escobar M, Rodríguez F, González-López MA. Prevalence of thyroid autoimmunity in spanish patients with chronic idiopathic urticaria: a case-controlstudy involving 343 subjects. J Eur Acad Dermatol Venereol 2016; 30: 692-93.
  • 10. Cebeci F, Tanrikut A, Topcu E et al. Association between chronic urticaria And thyroid autoimmunity. Eur J Dermatol 2006; 16: 402-5.
  • 11. Kasumagic-Halilovic E, Beslic N, Ovcina-Kurtovic N. Thyroid Autoimmunity in Patients with Chronic Urticaria. Med Arch 2017; 71: 29-31.
  • 12. Gül Ü, Çakmak S, Gönül M, Soylu S, Kılıç A. Kronik ürtikerde tiroid fonksiyon testleri ve tiroid otoantikorları istenmeli mi? Asthma Allergy Immunol 2009; 7: 39-43.
  • 13. Saraç G, Mantar İ, Sener S, Cenk H, Kapicioglu Y. Assessment of change in neutrophil-lymphocyte ratio, platelet-lymphocyteratio in patients with acute and chronic urticaria.J Tugut Ozal Med Cent 2018; 25: 719-22.
  • 14. Karabay EA, Çerman AA, Altunay İK. Serum C-reactive protein, neutrophil-lymphocyte ratio and uric acid levels in chronic spontaneous urticaria. Turkiye Klin J Dermatology 2016; 26: 125-31.
There are 14 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section Orıgınal Artıcle
Authors

Tuğba Songül Tat 0000-0001-6752-320X

Publication Date March 21, 2019
Published in Issue Year 2019

Cite

APA Tat, T. S. (2019). Kronik ürtikerli hastalarda troid otoimmünitesi ve artmış nötrofil lenfosit oranı. Turkish Journal of Clinics and Laboratory, 10(1), 52-56. https://doi.org/10.18663/tjcl.521024
AMA Tat TS. Kronik ürtikerli hastalarda troid otoimmünitesi ve artmış nötrofil lenfosit oranı. TJCL. March 2019;10(1):52-56. doi:10.18663/tjcl.521024
Chicago Tat, Tuğba Songül. “Kronik ürtikerli Hastalarda Troid otoimmünitesi Ve artmış nötrofil Lenfosit Oranı”. Turkish Journal of Clinics and Laboratory 10, no. 1 (March 2019): 52-56. https://doi.org/10.18663/tjcl.521024.
EndNote Tat TS (March 1, 2019) Kronik ürtikerli hastalarda troid otoimmünitesi ve artmış nötrofil lenfosit oranı. Turkish Journal of Clinics and Laboratory 10 1 52–56.
IEEE T. S. Tat, “Kronik ürtikerli hastalarda troid otoimmünitesi ve artmış nötrofil lenfosit oranı”, TJCL, vol. 10, no. 1, pp. 52–56, 2019, doi: 10.18663/tjcl.521024.
ISNAD Tat, Tuğba Songül. “Kronik ürtikerli Hastalarda Troid otoimmünitesi Ve artmış nötrofil Lenfosit Oranı”. Turkish Journal of Clinics and Laboratory 10/1 (March 2019), 52-56. https://doi.org/10.18663/tjcl.521024.
JAMA Tat TS. Kronik ürtikerli hastalarda troid otoimmünitesi ve artmış nötrofil lenfosit oranı. TJCL. 2019;10:52–56.
MLA Tat, Tuğba Songül. “Kronik ürtikerli Hastalarda Troid otoimmünitesi Ve artmış nötrofil Lenfosit Oranı”. Turkish Journal of Clinics and Laboratory, vol. 10, no. 1, 2019, pp. 52-56, doi:10.18663/tjcl.521024.
Vancouver Tat TS. Kronik ürtikerli hastalarda troid otoimmünitesi ve artmış nötrofil lenfosit oranı. TJCL. 2019;10(1):52-6.


e-ISSN: 2149-8296

The content of this site is intended for health care professionals. All the published articles are distributed under the terms of

Creative Commons Attribution Licence,

which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.